← Back to Library

Spectech lessons and updated hypotheses from 2024

Ben Reinhardt delivers a rare, unvarnished autopsy of the modern research ecosystem, arguing that the institutions we rely on to invent the future are actively strangling it. This is not a hopeful manifesto for change, but a sobering inventory of broken incentives, from the stranglehold of university monopolies to the collapse of corporate curiosity. For leaders navigating the gap between scientific promise and commercial reality, Reinhardt's 2024 retrospective offers a critical map of where the system is failing and where the only viable paths forward lie.

The Institutional Bottleneck

Reinhardt's central thesis is that the volume of ambitious, transformative ideas now exceeds the capacity of existing institutions to absorb them. He observes that "there are far more ideas that don't fit into existing institutions than a single organization can handle." This is not merely a complaint about bureaucracy; it is an observation of a structural mismatch. The author details how governments, despite their vast resources, are ill-equipped for ambitious research due to rigid categories and use-focused mandates that exclude basic science or specific applications.

Spectech lessons and updated hypotheses from 2024

The friction is palpable. Reinhardt notes that "working with the government eats time that a small team can barely afford," often to the point where a contract isn't worth pursuing because the reporting requirements would require hiring a dedicated administrator. This highlights a critical inefficiency: the administrative overhead of compliance is now so high that it actively filters out the very agility required for breakthrough innovation. The administration's rigid frameworks, while designed for accountability, are inadvertently creating a barrier to entry for the most experimental work.

"Universities have developed a monopoly on pre- and non-commercial research."

This monopoly, Reinhardt argues, has created a bottleneck where almost any non-commercial initiative is forced to anchor itself to a university, regardless of whether that environment is suitable. He shares anecdotes of state officials waiting months for updates from university partners and former federal workers rage-quitting after encountering even more bureaucracy within academia. The university, once a hub of pure inquiry, has become a massive, unwieldy bundle of roles—from sports to moral instruction to hedge fund management—that dilutes its ability to foster speculative technology. Critics might argue that universities remain the only viable source of deep talent and infrastructure, but Reinhardt's evidence suggests that this dependency is now a liability rather than an asset.

The Death of Corporate Curiosity

Perhaps the most sobering update in Reinhardt's analysis is the realization that the era of corporate-funded basic research is effectively over. He writes, "Corporate research has been gutted." The dream of building a consortium of corporate sponsors to fund ambitious, external research programs proved impossible. Modern corporations, driven by short-term equity expectations, have retreated from exploratory projects, focusing instead on scoped work to improve existing products.

The implications are severe. Without the safety net of corporate R&D labs, the burden of funding high-risk, long-term research falls entirely on philanthropy and the government. Reinhardt points out that "it is harder to fund 1-off ambitious research programs in materials and manufacturing than we thought," largely because philanthropists prefer health and climate, leaving other critical fields in the cold. This creates a vicious cycle: you need a track record to get funding, but you need funding to build a track record.

"In many domains, IP is net negative."

Reinhardt challenges the conventional wisdom that intellectual property drives innovation. Instead, he argues that in many sectors, IP considerations "drastically increase transaction costs — wasting tons of time, creating secrets and miscommunication, and potentially killing collaborations." The legalistic nature of modern R&D, where organizations are "basically run by lawyers," stifles the open exchange of ideas necessary for rapid iteration. While some might argue that IP protection is essential to recoup massive R&D investments, Reinhardt suggests that the current system creates more friction than value, particularly in materials and manufacturing where collaboration is key.

The Principal Investigator Problem

A significant portion of Reinhardt's critique targets the "Principal Investigator" (PI) model, which dominates funding across universities, national labs, and even corporate R&D. In this system, grants are awarded to specific individuals rather than institutions or teams. Reinhardt argues that "PI-based funding is holding back progress," forcing the best researchers to spend up to 40% of their time writing proposals rather than doing science.

This model warps career tracks and incentivizes safe, incremental projects over risky, transformative ones. The expectation that a single person must be the idea generator, technical expert, and salesperson creates a bottleneck that limits the scale of what can be achieved. Reinhardt suggests that the "organizational pincushion effect"—where external funders modify internal incentives project by project—fragments research organizations and prevents them from developing a cohesive strategy.

"We need new organizations to specialize in tackling subsets of these roles."

The solution, according to Reinhardt, is to "unbundle" the university. We need new institutions designed specifically for pre-commercial technology research, free from the competing demands of sports, moral instruction, and endowment management. These new entities would need to figure out how to use AI not just as a tool, but as a catalyst for "organizational reconfiguration," moving beyond simple automation to fundamentally changing how research is conducted.

Bottom Line

Reinhardt's analysis is a powerful indictment of the current research infrastructure, correctly identifying that the "valley of death" between idea and product has widened due to systemic inefficiencies. His strongest argument lies in exposing the mismatch between the scale of modern ambition and the capacity of our legacy institutions. However, the piece's biggest vulnerability is its lack of a concrete roadmap for funding these new, unbundled institutions; identifying the problem is easier than solving the capital allocation crisis. Readers should watch for how new institutional models attempt to bypass the PI funding trap and whether they can scale without the very university monopolies they seek to replace.

Sources

Spectech lessons and updated hypotheses from 2024

by Ben Reinhardt · · Read full article

In the spirit of being an institutional experiment, we wanted to share some of the key takeaways from 2024: what we got right and what we are updating from our hypotheses going into the year, some lessons from 2024, and then outline some big hypotheses going into 2025.

In addition to our actual outputs, we hope that through the feedback loop between meta-scientific ideas and executing on those ideas, we can pave the way for other institutional experiments. I realize that each of these points wants its own memo unpacking it. I hope to create those over the coming year.

Below is a summary of our takeaways, divided into hypotheses from last year that we want to double down on, beliefs that we have updated or were wrong about, and new hypotheses going into 2025. I expand on each one further down. (As a gentle nudge that we are subscriber- and donor- supported, the updated and new hypotheses are paywalled for now.)

Double Down:

There are far more ideas that don’t fit into existing institutions than a single organization can handle.

Governments run into fundamental tensions around ambitious research.

Working with Bureaucracies is incredibly hard for a new organization.

Materials and manufacturing are an incredibly impactful place to focus for new institutional models.

Universities have developed a monopoly on pre- and non-commercial research.

Exclusively working with external performers in the 21st century is severely limiting.

Updated/Wrong

Corporate research has been gutted.

It is harder to fund 1-off ambitious research programs in materials and manufacturing than we thought.

There are a lot of subtle annoying things about nonprofits.

New

Universities need to be unbundled.

PI-based funding is holding back progress.

As an organization, we need to figure out how to use AI well.

There are a lot of systemic things widening the ‘valley of death.’

In many domains, IP is net negative.

Double down.

I think most of our hypotheses going into 2024 were spot on. I’m not going to touch on all of them, but I’ll highlight the most important ones that I want to double down on and the additional evidence for them.

There are far more ideas that don’t fit into existing institutions than a single organization can handle. Throughout 2024, we constantly ran into people with ambitious ideas that don’t fit into normal institutional boxes: some of them were stuck, some of them were struggling to cram ...